Kura Oncology, Inc.
KURA· Nasdaq
Released Feb 26, 2025, after the close
10-K filed Feb 28, 2025, 59 days after period end · 0000950170-25-029975
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$19.22M | -$42.79M | -$33.11M | -$32.74M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kura Oncology, Inc. · CIK 1422143 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2024 · filed Feb 28, 2025 · 59 d after period end
1.4% from the close of Feb 26, 2025 to the close of Feb 27, 2025, the first after the release.